Add to Watchlist Create Alerts

Real-Time Last Update

Last Sale Cboe BZX Real-Time

Volume

CUMBERLAND PHARMACEUTICALS REPORTS 17% REVENUE GROWTH FOR FULL YEAR 2022

PR Newswire - Tue Mar 7, 2023

2022 highlights include its acquisition of Sancuso^® and move to new headquarters

NASHVILLE, Tenn., March 7, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company today announced full year 2022 financial results and provided a Company update. Net revenues grew 17% over the prior year to $42 million, resulting in $8 million in cash flow from operations.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

inside the market

Dividend investing has lost its mojo. Here’s why – and how to adapt

inside the market

The Globe Investing Club 2024: Let the competition begin!

Here’s the real reason your Canadian stocks can’t keep up

Dow ends above 40,000 milestone, TSX also at fresh record high

number cruncher

U.S technology stocks with earnings and price momentum

report on business

Lightspeed Commerce stock soars on better-than-expected profit forecast

GameStop, AMC dive further as meme stocks rally tapers off

The close: Dow briefly hits 40,000 milestone, TSX rises on upbeat earnings